Abstract:Background: Several (online) adaptive radiotherapy procedures are available to maximize healthy tissue sparing in the presence of inter/intrafractional motion during stereotactic body radiotherapy (SBRT) on an MR-linac. The increased treatment complexity and the motion-delivery interplay during these treatments require MR-compatible motion phantoms with time-resolved dosimeters to validate end-to-end workflows. This is not possible with currently available phantoms. Purpose: Here, we demonstrate a new commercial hybrid film-scintillator cassette, combining high spatial resolution radiochromic film with four time-resolved plastic scintillator dosimeters (PSDs) in an MRI-compatible motion phantom. Methods: First, the PSD's performance for consistency, dose linearity, and pulse repetition frequency (PRF) dependence was evaluated using an RW3 solid water slab phantom. We then demonstrated the MRI4D scintillator cassette's suitability for time-resolved and motion-included quality assurance for adapt-to-shape (ATS), trailing, gating, and multileaf collimator (MLC) tracking adaptations on a 1.5 T MR-linac. To do this, the cassette was inserted into the Quasar MRI4D phantom, which we used statically or programmed with artificial and patient-derived motion. Simultaneously with dose measurements, the beam-gating latency was estimated from the time difference between the target entering/leaving the gating window and the beam-on/off times derived from the time-resolved dose measurements. Results: Experiments revealed excellent detector consistency (standard deviation ≤ $\le$ 0.6%), dose linearity (R2 = 1), and only very low PRF dependence ( ≤ $\le$ 0.4%). The dosimetry cassette demonstrated a near-perfect agreement during an ATS workflow between the time-resolved PSD and treatment planning system (TPS) dose (0%-2%). The high spatial resolution film measurements confirmed this with a 1%/1-mm local gamma pass-rate of 90%. When trailing patient-derived prostate motion for a prostate SBRT delivery, the time-resolved cassette measurements demonstrated how trailing mitigated the motion-induced dose reductions from 1%-17% to 1%-2% compared to TPS dose. The cassette's simultaneously measured spatial dose distribution highlighted the dosimetric gain of trailing by improving the 3%/3-mm local gamma pass-rates from 80% to 97% compared to the static dose. Similarly, the cassette demonstrated the benefit of real-time adaptations when compensating patient-derived respiratory motion by showing how the TPS dose was restored from 2%-56% to 0%-12% (gating) and 1%-26% to 1%-7% (MLC tracking) differences. Larger differences are explainable by TPS-PSD coregistration uncertainty combined with a steep dose gradient outside the PTV. The cassette also demonstrated how the spatial dose distributions were drastically improved by the real-time adaptations with 1%/1-mm local gamma pass-rates that were increased from 8 to 79% (gating) and from 35 to 89% (MLC tracking). The cassette-determined beam-gating latency agreed within ≤ $\le$ 12 ms with the ground truth latency measurement. Film and PSD dose agreed well for most cases (differences relative to TPS dose < $<$ 4%), while film-PSD coregistration uncertainty caused relative differences of 5%-8%. Conclusions: This study demonstrates the excellent suitability of a new commercial hybrid film-scintillator cassette for simultaneous spatial, temporal, and motion-included dosimetry.

Technical note: Characterization of a multi‐point scintillation dosimetry research platform for a low‐field MR‐Linac

Performance of the HYPERSCINT scintillation dosimetry research platform for the 1.5 T MR-linac

Computational and experimental small field dosimetry using a commercial plastic scintillator detector for the 0.35 T MR-linac

Performance characterization of a novel hybrid dosimetry insert for simultaneous spatial, temporal, and motion-included dosimetry for MR-linac

Dosimetric characterization of a novel commercial plastic scintillation detector with an MR-Linac

Dosimetric performance of a multi-point plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate brachytherapy

Clinical reference dosimetry for the 0.5 T inline rotating biplanar Linac‐MR

Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance

Field output correction factors using a fully characterized plastic scintillation detector

Plastic scintillator dosimetry of ultrahigh dose-rate 200 MeV electrons at CLEAR

Technical note: A simple method for patient‐specific quality assurance for lateral targets on a 1.5 T MR‐Linac

Systematic evaluation of spatial resolution and gamma criteria for quality assurance with detector arrays in stereotactic radiosurgery

Comparative optic and dosimetric characterization of the HYPERSCINT scintillation dosimetry research platform for multipoint applications

Determination of the quenching correction factors for plastic scintillation detectors in therapeutic high-energy proton beams

First linac‐mounted photon counting detector for image guided radiotherapy: Planar image quality characterization

Development of a three-dimensional scintillation detector for pencil beam verification in proton therapy patient-specific quality assurance

Design and Characterization of a Novel Scintillator Array for In Vivo Monitoring During UHDR PBS Proton Therapy

Performance assessment of a 2D array of plastic scintillation detectors for IMRT quality assurance

Characterization of the plastic scintillation detector Exradin W2 for small field dosimetry

A Single Detector Energy-Resolved Proton Radiography System: a Proof of Principle Study by Monte Carlo Simulations

Characterization of Plastic Scintillator Detector for In Vivo Dosimetry in Gynecologic Brachytherapy